These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 23768512)

  • 21. Mild POMGnT1 mutations underlie a novel limb-girdle muscular dystrophy variant.
    Clement EM; Godfrey C; Tan J; Brockington M; Torelli S; Feng L; Brown SC; Jimenez-Mallebrera C; Sewry CA; Longman C; Mein R; Abbs S; Vajsar J; Schachter H; Muntoni F
    Arch Neurol; 2008 Jan; 65(1):137-41. PubMed ID: 18195152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α-dystroglycan and muscular dystrophy.
    Larson AA; Baker PR; Milev MP; Press CA; Sokol RJ; Cox MO; Lekostaj JK; Stence AA; Bossler AD; Mueller JM; Prematilake K; Tadjo TF; Williams CA; Sacher M; Moore SA
    Skelet Muscle; 2018 May; 8(1):17. PubMed ID: 29855340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Congenital muscular dystrophy and generalized epilepsy caused by GMPPB mutations.
    Raphael AR; Couthouis J; Sakamuri S; Siskind C; Vogel H; Day JW; Gitler AD
    Brain Res; 2014 Aug; 1575():66-71. PubMed ID: 24780531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limb-girdle muscular dystrophy due to GMPPB mutations: A case report and comprehensive literature review.
    Sun L; Shen D; Xiong T; Zhou Z; Lu X; Cui F
    Bosn J Basic Med Sci; 2020 May; 20(2):275-280. PubMed ID: 30684953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two patients with GMPPB mutation: The overlapping phenotypes of limb-girdle myasthenic syndrome and limb-girdle muscular dystrophy dystroglycanopathy.
    Montagnese F; Klupp E; Karampinos DC; Biskup S; Gläser D; Kirschke JS; Schoser B
    Muscle Nerve; 2017 Aug; 56(2):334-340. PubMed ID: 27874200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limb girdle muscular dystrophy type 2I: No correlation between clinical severity, histopathology and glycosylated α-dystroglycan levels in patients homozygous for common FKRP mutation.
    Alhamidi M; Brox V; Stensland E; Liset M; Lindal S; Nilssen Ø
    Neuromuscul Disord; 2017 Jul; 27(7):619-626. PubMed ID: 28479227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward understanding tissue-specific symptoms in dolichol-phosphate-mannose synthesis disorders; insight from DPM3-CDG.
    van Tol W; Michelakakis H; Georgiadou E; van den Bergh P; Moraitou M; Papadimas GK; Papadopoulos C; Huijben K; Alsady M; Willemsen MA; Lefeber DJ
    J Inherit Metab Dis; 2019 Sep; 42(5):984-992. PubMed ID: 30931530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy.
    Godfrey C; Escolar D; Brockington M; Clement EM; Mein R; Jimenez-Mallebrera C; Torelli S; Feng L; Brown SC; Sewry CA; Rutherford M; Shapira Y; Abbs S; Muntoni F
    Ann Neurol; 2006 Nov; 60(5):603-610. PubMed ID: 17044012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.
    Belaya K; Rodríguez Cruz PM; Liu WW; Maxwell S; McGowan S; Farrugia ME; Petty R; Walls TJ; Sedghi M; Basiri K; Yue WW; Sarkozy A; Bertoli M; Pitt M; Kennett R; Schaefer A; Bushby K; Parton M; Lochmüller H; Palace J; Muntoni F; Beeson D
    Brain; 2015 Sep; 138(Pt 9):2493-504. PubMed ID: 26133662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoglycosylation of dystroglycan due to T192M mutation: a molecular insight behind the fact.
    Bhattacharya S; Das A; Ghosh S; Dasgupta R; Bagchi A
    Gene; 2014 Mar; 537(1):108-14. PubMed ID: 24361964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synaptic defects in a Drosophila model of congenital muscular dystrophy.
    Wairkar YP; Fradkin LG; Noordermeer JN; DiAntonio A
    J Neurosci; 2008 Apr; 28(14):3781-9. PubMed ID: 18385336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan.
    Matsumoto H; Hayashi YK; Kim DS; Ogawa M; Murakami T; Noguchi S; Nonaka I; Nakazawa T; Matsuo T; Futagami S; Campbell KP; Nishino I
    Neuromuscul Disord; 2005 May; 15(5):342-8. PubMed ID: 15833426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I.
    Boito CA; Melacini P; Vianello A; Prandini P; Gavassini BF; Bagattin A; Siciliano G; Angelini C; Pegoraro E
    Arch Neurol; 2005 Dec; 62(12):1894-9. PubMed ID: 16344347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained limb-girdle muscle weakness.
    Johnson K; Bertoli M; Phillips L; Töpf A; Van den Bergh P; Vissing J; Witting N; Nafissi S; Jamal-Omidi S; Łusakowska A; Kostera-Pruszczyk A; Potulska-Chromik A; Deconinck N; Wallgren-Pettersson C; Strang-Karlsson S; Colomer J; Claeys KG; De Ridder W; Baets J; von der Hagen M; Fernández-Torrón R; Zulaica Ijurco M; Espinal Valencia JB; Hahn A; Durmus H; Willis T; Xu L; Valkanas E; Mullen TE; Lek M; MacArthur DG; Straub V
    Skelet Muscle; 2018 Jul; 8(1):23. PubMed ID: 30060766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limb-girdle muscular dystrophy type 2I is not rare in Taiwan.
    Liang WC; Hayashi YK; Ogawa M; Wang CH; Huang WT; Nishino I; Jong YJ
    Neuromuscul Disord; 2013 Aug; 23(8):675-81. PubMed ID: 23800702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dilated cardiomyopathy and limb-girdle muscular dystrophy-dystroglycanopathy due to novel pathogenic variants in the DPM3 gene.
    Svahn J; Laforêt P; Vial C; Streichenberger N; Romero N; Bouchet-Séraphin C; Bruneel A; Dupré T; Seta N; Menassa R; Michel-Calemard L; Stojkovic T
    Neuromuscul Disord; 2019 Jul; 29(7):497-502. PubMed ID: 31266720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zebrafish models for human FKRP muscular dystrophies.
    Kawahara G; Guyon JR; Nakamura Y; Kunkel LM
    Hum Mol Genet; 2010 Feb; 19(4):623-33. PubMed ID: 19955119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in GMPPB Presenting with Pseudometabolic Myopathy.
    Panicucci C; Fiorillo C; Moro F; Astrea G; Brisca G; Trucco F; Pedemonte M; Lanteri P; Sciarretta L; Minetti C; Santorelli FM; Bruno C
    JIMD Rep; 2018; 38():23-31. PubMed ID: 28456886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FKRP mutations cause congenital muscular dystrophy 1C and limb-girdle muscular dystrophy 2I in Asian patients.
    Awano H; Saito Y; Shimizu M; Sekiguchi K; Niijima S; Matsuo M; Maegaki Y; Izumi I; Kikuchi C; Ishibashi M; Okazaki T; Komaki H; Iijima K; Nishino I
    J Clin Neurosci; 2021 Oct; 92():215-221. PubMed ID: 34509255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity.
    Jimenez-Mallebrera C; Torelli S; Feng L; Kim J; Godfrey C; Clement E; Mein R; Abbs S; Brown SC; Campbell KP; Kröger S; Talim B; Topaloglu H; Quinlivan R; Roper H; Childs AM; Kinali M; Sewry CA; Muntoni F
    Brain Pathol; 2009 Oct; 19(4):596-611. PubMed ID: 18691338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.